Johnson & Johnson as of Sept. 30, 2021
Portfolio Holdings for Johnson & Johnson
Johnson & Johnson holds 25 positions in its portfolio as reported in the September 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Illumina (ILMN) | 28.8 | $329M | 810k | 405.61 | |
| Arrowhead Pharmaceuticals (ARWR) | 17.9 | $204M | 3.3M | 62.43 | |
| Fate Therapeutics (FATE) | 17.6 | $200M | 3.4M | 59.27 | |
| Legend Biotech Corporation Sponsored Ads (LEGN) | 7.2 | $82M | 1.6M | 50.56 | |
| Cue Health (HLTHQ) | 5.7 | $66M | 5.5M | 11.81 | |
| CVRX (CVRX) | 5.1 | $58M | 3.5M | 16.54 | |
| Protagonist Therapeutics (PTGX) | 3.8 | $43M | 2.4M | 17.72 | |
| Procept Biorobotics Corp (PRCT) | 3.4 | $39M | 1.0M | 38.15 | |
| Meiragtx Holdings (MGTX) | 3.4 | $38M | 2.9M | 13.18 | |
| Fusion Pharmaceuticals | 2.6 | $29M | 3.7M | 7.92 | |
| Vor Biopharma (VOR) | 1.5 | $17M | 1.1M | 15.68 | |
| Point Biopharma Global | 0.7 | $7.7M | 1.0M | 7.69 | |
| Chardan Healthcare Acqu- Ord (PHGE) | 0.6 | $6.5M | 2.1M | 3.06 | |
| Adicet Bio (ACET) | 0.5 | $5.7M | 729k | 7.84 | |
| Phasebio Pharmaceuticals | 0.4 | $5.0M | 1.6M | 3.11 | |
| Somalogic | 0.3 | $3.5M | 281k | 12.39 | |
| Aldeyra Therapeutics (ALDX) | 0.3 | $3.5M | 395k | 8.78 | |
| Castlight Health CL B | 0.1 | $1.3M | 811k | 1.57 | |
| Neuropace (NPCE) | 0.1 | $879k | 55k | 15.86 | |
| Tracon Pharmaceuticals | 0.0 | $325k | 84k | 3.87 | |
| Catalyst Biosciences | 0.0 | $275k | 67k | 4.11 | |
| Zymergen | 0.0 | $218k | 17k | 13.17 | |
| Pulmonx Corp (LUNG) | 0.0 | $203k | 5.6k | 36.00 | |
| Senseonics Hldgs (SENS) | 0.0 | $185k | 55k | 3.39 | |
| Graybug Vision Com Shs | 0.0 | $164k | 50k | 3.31 |
